Pediatrix Medical Group Inc (N:MD)

Business Focus: Healthcare Facilities & Services

Sector:  Healthcare Industry:  Healthcare Facilities & Services
 
See Regulatory Filings on SEC
Company Contact
Address: 1301 CONCORD TERRACE
SUNRISE FL 33323
Tel: 1-954-3840175
Website: https://www.pediatrix.com
IR: See website
<
Key People
Mark S. Ordan
Executive Chairman of the Board
James D. Swift
Chief Executive Officer, Director
C. Marc Richards
Chief Financial Officer, Executive Vice President
Curtis B. Pickert
Chief Operating Officer, Executive Vice President
Mary Ann E. Moore
Executive Vice President, General Counsel, Secretary
Lee Wood
Executive Vice President - National and Market Operations
Business Overview
Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Company's affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. Its national network comprises over 2,620 affiliated physicians, including 1,330 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 580 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
Financial Overview
For the fiscal year ended 31 December 2023, Pediatrix Medical Group Inc revenues increased 1% to $1.99B. Net loss before extraordinary items totaled $60.4M vs. income of $62.6M. Revenues reflect Neonatology and other pediatric subspecialties segment increase of 2% to $1.6B, Maternal-fetal medicine segment increase of 1% to $319.1M. Net loss reflects Practice salaries and benefits increase of 5% to $1.45B (expense).
Employees: 2,900 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $1,296M as of Dec 31, 2023
Annual revenue (TTM): $1,995M as of Dec 31, 2023
EBITDA (TTM): $194.02M as of Dec 31, 2023
Net annual income (TTM): -$60.41M as of Dec 31, 2023
Free cash flow (TTM): $104.00M as of Dec 31, 2023
Net Debt Last Fiscal Year: $455.59M as of Dec 31, 2023
Shares outstanding: 84,122,979 as of Feb 15, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.